Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA] -- Ignore unavailable to you. Want to Upgrade?

To: marquis103 who wrote (726)	12/18/1997 10:49:00 AM
From: luis a. garcia	Read Replies (1) \| Respond to of 1115

aaahh thousands is right.. Hey Lidak contracts better investor relations...firm... SOURCE: Lidak Pharmaceuticals LIDAK Pharmaceuticals Retains StartUp Solutions LLC, An Investor Relations and Corporate Development Advisory Firm LA JOLLA, Calif., Dec. 18 /PRNewswire/ -- LIDAK Pharmaceuticals (Nasdaq: LDAKA - news) today announced it had retained StartUp Solutions LLC, a New York-based firm, to provide comprehensive investor relations and corporate development advisory services, effective January 1, 1998. ''We are pleased to announce that StartUp Solutions will be assisting LIDAK with our investor relations and corporate development activities,'' commented David H. Katz, M.D., LIDAK's President and Chief Executive Officer. ''As it pertains to investor relations activities, the StartUp principals have unique backgrounds managing life sciences companies and in senior positions in health care investment banking. We look forward to capitalizing on their experience to raise our visibility within the investment community, and to actively contribute to our ongoing corporate development activities.'' StartUp Solutions LLC provides its clients with a unique combination of investor relations and corporate finance advice and execution service, leveraging the synergies between investor relations and corporate development activities to assist clients in enhancing shareholder value. Its principals have extensive experience managing life science companies and in health care investment banking, and have strong backgrounds in corporate partnering, licensing, mergers and acquisitions and corporate finance. ''We are extremely excited to be working with LIDAK Pharmaceuticals,'' stated Steven H. Rouhandeh, StartUp's Chairman and Chief Executive Officer. ''We believe LIDAK possesses the strengths which we can help them build upon -- a strong, diverse technology portfolio, world-class corporate partnerships, and an experienced management team. We look forward to assisting them in communicating the LIDAK investment message to the investment community, and assisting them in corporate development efforts pertaining to commercialization of current technologies and the expansion into new areas, as opportunities arise.'' Now if they can keep Dc Katz busy with his work (LIKE SUBMITTING That NDA...) and he can let them do theirs....(good investor relations...) we may have a winning combo here. merry xmas LDAKA people wherever you are.... luis